Patents Assigned to Strohtech, Inc.
  • Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein
    Patent number: 5296466
    Abstract: The invention is directed to a method for the prophylaxis or treatment of an animal for deleterious physiological effects such as systemic hypotension caused by nitric oxide production induced by a biological response modifier. Examples of such biological response modifiers include but are not limited to a cytokine and an endotoxin. The invention is also directed to a method for the treatment of septic shock.
    Type: Grant
    Filed: February 19, 1992
    Date of Patent: March 22, 1994
    Assignees: Board of Regents, The University of Texas System, Strohtech, Inc., Duke University
    Inventors: Robert G. Kilbourn, Joseph De Angelo, Joseph Bonaventura